NEIMETH
Neimeth International Pharmaceuticals Plc · Healthcare · Main Board
The last 15 trading days
Peers in Healthcare
NEIMETH beside its sector
| Company | Price | Today | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| MECURE | ₦56.20 | — | 224.80B | 34.7 | 0.57% |
| FIDSON | ₦80.00 | +5.96% | 192.00B | 19.4 | 1.88% |
| MAYBAKER | ₦39.00 | — | 67.28B | 15.2 | — |
| NEIMETH | ₦6.70 | +3.08% | 28.63B | 29.1 | — |
P/E and dividend yield use each company’s latest audited figures — dashes fill in as our fundamentals library covers more companies. A comparison is context, not a verdict: cheaper is not always better, and dearer is not always worse.
Price statistics
High (15d)
₦8.00
Low (15d)
₦6.50
Position in range
13%
Avg volume (15d)
2,501,851
Market cap
28.63B
P/E ratio
29.13
Shares outstanding
4.27B
Deals today
155
Return figures (1 month, 1 year…) appear as our daily price history builds — 15 trading days collected so far.
Past performance describes the past. It does not predict anything.
Technical readings — facts, not signals
RSI (14-day)
34
50-day average
—
200-day average
—
These are measurements, not recommendations. What they mean — and don’t mean — is taught in the Lab, where you can run all 31 indicators on the chart yourself.
Five-year financials — figures in ₦ billions, per-share lines in ₦
In plain words: in 2022, customers paid NEIMETH about ₦3 billion. By 2025 that had grown to ₦7 billion — roughly 3 times bigger.
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue | 2.9 | ▼2.2 | ▲4.5 | ▲7.4 |
| Profit before tax | -0.3 | ▼-1.7 | ▲-0.9 | ▲1.3 |
| Profit after tax | -0.3 | ▼-1.8 | ▲-0.9 | ▲1 |
| Earnings per share (₦) | -0.17 | ▼-0.42 | ▲-0.21 | ▲0.23 |
| Dividend per share (₦) | — | — | — | — |
| Free cash flow | -1.1 | ▼-1.7 | ▲-0.3 | ▲1.2 |
| Total assets | — | — | — | — |
| Shareholders' funds | — | — | — | — |
💪 Return on equity
—
🧮 Net margin
13.3%
💰 Dividend yield
—
🎁 Payout ratio
—
🚀 Revenue growth /yr
36.2%
📈 Profit growth /yr
—
📖 What do these lines mean? — in plain words
Figures from audited annual reports and results statements — latest source. Ratios are our arithmetic on those figures. Profit is an opinion; cash is a fact — that is why free cash flow is here.
News mentioning NEIMETH
Nothing tagged yet. Browse all coverage in News or search the wider web.
How to know a stock — the checklist
Read the last five annual reports: is revenue growing, is profit real, are dividends paid from earnings? Learn who runs the company and how long they have stayed. Understand what the company sells and who pays for it — if you cannot explain that in one sentence, keep reading before you buy. Compare the P/E with the sector, not with hope. And check how often the stock actually trades: thin volume means your exit may be slow.
This page shows facts and teaches method. It never rates a stock and never tells you what to buy — that decision, made with open eyes, is yours. Education, not investment advice.